As we continue with Cord Blood Awareness month, we will reflect on some of the most revolutionary clinical trials using umbilical cord blood over the last two decades. Cord blood and brain injury Traumatic brain injury (TBI) is a major cause of disability and...
Cells4Life is proud to announce our membership of the All-Party Parliamentary Group for Longevity (APPG). Our aim is to deliver 5 extra years of healthy life expectancy to all British citizens by 2035 while minimising health inequalities. Regenerative medicine will...
Researchers in Abu Dhabi have developed a potential stem cell treatment for COVID-19 patients with initial data showing promising results. Stem cells can currently treat a wide array of conditions, from immune disorder to blood cancers – and this list keeps on...
The emotional and physical journey of pregnancy is an exciting and fascinating time for women. As expectant mums become more knowledgeable about their pregnancies, they begin to wonder about the development of their baby inside the womb. A common question that is...
Last week, Cells4Life’s sister company, Stabilitech, featured on ITV’s Tonight programme “The Race for a Cure: Making Britain Safer”. This episode looks at making a COVID-19 vaccine. You can watch the full interview by watching the video...
The sister company of Cells4Life, Stabilitech Biopharma, have been formally recognised by the World Health Organisation (WHO) as an official vaccine developer. Stabilitech board member Dr Jeff Drew, who is also the co-founder of Cells4Life, noted: “The WHO is a...
